                         SEQUENCE LISTING

<110>  Valin Technologies Ltd.
 
<120>  PROCESS FOR PREPARING INSULIN

<130>  VLN-002 PCT

<150>  61/761712
<151>  2013-02-07

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  54
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  1

Arg Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu 
1               5                   10                  15      


Tyr Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr Arg 
            20                  25                  30          


Arg Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln 
        35                  40                  45              


Leu Glu Asn Tyr Cys Gly 
    50                  


<210>  2
<211>  117
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic polypeptide

<400>  2

Met Ala Thr Lys Ala Val Ser Val Leu Lys Gly Asp Gly Pro Val Gln 
1               5                   10                  15      


Gly Ile Ile Asn Phe Glu Gln Lys Glu Ser Asn Gly Pro Val Lys Val 
            20                  25                  30          


Trp Gly Ser Ile Lys Gly Leu Thr Glu Gly Leu His Gly Phe His Val 
        35                  40                  45              


His Glu Phe Gly Asp Asn Thr Ala Gly Ser Thr Ser Ala Gly Pro Arg 
    50                  55                  60                  


Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr 
65                  70                  75                  80  


Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr Arg Arg 
                85                  90                  95      


Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu 
            100                 105                 110         


Glu Asn Tyr Cys Gly 
        115         


<210>  3
<211>  354
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic polynucleotide

<400>  3
atggcaacca aagcagttag cgttctgaaa ggtgatggtc cggttcaggg cattattaat       60

tttgaacaga aagaaagcaa tggtccggtt aaagtttggg gtagcattaa aggtctgacc      120

gaaggtctgc atggttttca tgttcatgaa tttggcgata ataccgcagg tagcaccagc      180

gcaggcccgc gttttgttaa tcagcatctg tgtggtagcc atctggttga agcactgtat      240

ctggtttgtg gtgaacgcgg ttttttttat accccgaaaa cccgtcgtgg tattgttgaa      300

cagtgttgta ccagcatttg tagcctgtat cagctggaaa attattgcgg ctaa            354


<210>  4
<211>  21
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  4

Gly Ile Val Glu Gln Cys Cys Thr Ser Ile Cys Ser Leu Tyr Gln Leu 
1               5                   10                  15      


Glu Asn Tyr Cys Gly 
            20      


<210>  5
<211>  32
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  5

Phe Val Asn Gln His Leu Cys Gly Ser His Leu Val Glu Ala Leu Tyr 
1               5                   10                  15      


Leu Val Cys Gly Glu Arg Gly Phe Phe Tyr Thr Pro Lys Thr Arg Arg 
            20                  25                  30          


